NYU Langone, Philips embark on $115M monitoring ecosystem

NYU Langone Health, based in New York City, entered into an eight-year partnership worth $115 million with Royal Philips that is aimed at advancing patient care through innovation. 

Advertisement

Under the partnership, NYU Langone will integrate Philips’ IntelliSite Pathology solution, Lumify Handheld Ultrasound, Patient Information Center iX and Capsule Medical Device Information Platform into its existing infrastructure, according to a Nov. 16 news release from Philips.  

The partnership, led by Dafna Bar-Sagi, PhD, executive vice president and vice dean for science, chief scientific officer of NYU Langone, extends to new research programs focusing on the future of digital pathology, patient monitoring, ultrasound and MRI. 

The collaboration aims to deliver seamless integration across the network, utilizing a predictable enterprise-monitoring-as-a-service subscription model, according to the release

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.